4//SEC Filing
Brusegard David 4
Accession 0001363585-13-000006
CIK 0001059784other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:29 PM ET
Size
5.6 KB
Accession
0001363585-13-000006
Insider Transaction Report
Form 4
Brusegard David
Chief Operating Officer
Transactions
- Award
Common Stock Purchase Option (right to buy)
2013-04-01+1,928,925→ 1,928,925 totalExercise: $0.00From: 2013-04-01Exp: 2018-04-01→ COMMON STOCK (1,928,925 underlying)
Footnotes (1)
- [F1]On March 5, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 1,928,925 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective April 1, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeother
Related Parties
1- filerCIK 0001516920
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:29 PM ET
- Size
- 5.6 KB